Pharma Two B raises $30 million for Parkinson’s treatment trial

  Israeli Pharma Two B Ltd., a developer of treatments for Parkinson’s disease, has completed its third round of financing. The $30 million funding round was led by Israel Biotech Fund (IBF) which identified More...